Following an announcement from Health Minister Ryan Park MP, New South Wales has become the first Australian jurisdiction to authorise the extended supply of oral contraceptives by pharmacists under the NSW Pharmacy Trial.
The Pharmaceutical Society of Australia (PSA) New South Wales President Luke Kelly FPS welcomed the start of the program, which was first announced in November 2022.
“Improving safe access to contraception is essential to improving health care for all Australians,” Mr Kelly said.
“Pharmacists participating in the trial will be able to continue the supply of an existing low-risk contraceptive without renewed prescription, better supporting contraceptive adherence as well as saving patients time and money.
“This trial will make oral contraception more accessible to more women in New South Wales.
“Pharmacists are ready and able to improve healthcare for all Australians, offering safe, accessible, and equitable access to contraception and expert advice on their options.
“Pharmacists are the most accessible health care professional and are well placed to support patients in accessing timely care.
“This is about making sure that Australians can access safe contraception when and where they need it,’ Mr Kelly concluded.
